Wen-Yang Lin

National University of Kaohsiung — Taiwan

Computer Science · Physical Sciences

18h-index1.3kcitations177works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Data Mining Algorithms and Applications(61), Rough Sets and Fuzzy Logic(49), Lung Cancer Treatments and Mutations(41), Data Management and Algorithms(22), RNA modifications and cancer(18)

Publications177 total

SEDA: A Self-Adapted Entity-Centric Data Augmentation for Boosting Gird-based Discontinuous NER Models
ArXiv.org·2025Open Access
Beyond GPT-NER: ChatGPT as Ensemble Arbitrator for Discontinuous Named Entity Recognition in Health Corpora
Studies in health technology and informatics·2025Open Access
On Fusing ChatGPT and Ensemble Learning in Discon-tinuous Named Entity Recognition in Health Corpora
arXiv (Cornell University)·2024· 2 citedOpen Access
ADR-DQPU: A Novel ADR Signal Detection Using Deep Reinforcement and Positive-Unlabeled Learning
IEEE Journal of Biomedical and Health Informatics·2024· 1 cited
Stacking Ensemble of Disproportionality Indicators for Adverse Vaccine Reactions Detection—An Empirical Study on Predicting Adverse Reactions of COVID-19 Vaccines
2023
Table S1 from A Functional Taxonomy of Tumor Suppression in Oncogenic KRAS–Driven Lung Cancer
2023Open Access
Supplementary Tables S2-S6 from Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response <i>In Vivo</i>
2023Open Access
Table S1 from A Functional Taxonomy of Tumor Suppression in Oncogenic KRAS–Driven Lung Cancer
2023Open Access
Data from Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response <i>In Vivo</i>
2023Open Access
Figure S1-S17, Table S3 from A Functional Taxonomy of Tumor Suppression in Oncogenic KRAS–Driven Lung Cancer
2023Open Access
Data from A Functional Taxonomy of Tumor Suppression in Oncogenic KRAS–Driven Lung Cancer
2023Open Access
Figure S1-S17, Table S3 from A Functional Taxonomy of Tumor Suppression in Oncogenic KRAS–Driven Lung Cancer
2023Open Access
Supplementary Figures S11-S14 from Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response <i>In Vivo</i>
2023Open Access
Supplementary Figures S8-S10 from Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response <i>In Vivo</i>
2023Open Access
Supplementary Tables S2-S6 from Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response <i>In Vivo</i>
2023Open Access
Supplementary Table S1 from Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response <i>In Vivo</i>
2023Open Access
Supplementary Figures S4-S7 from Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response <i>In Vivo</i>
2023Open Access
Data from Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response <i>In Vivo</i>
2023Open Access
Supplementary Figures S8-S10 from Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response <i>In Vivo</i>
2023Open Access
Table S2 from A Functional Taxonomy of Tumor Suppression in Oncogenic KRAS–Driven Lung Cancer
2023Open Access
page 1 of 9Next →

Frequent Co-authors

Tzung‐Pei Hong(17), Ming-Cheng Tseng(13), Jerry Chun‐Wei Lin(5), Rong Jeng(5), Guo-Cheng Lan(4), Ja-Hwung Su(4), Jie-Teng Wang(4), Chin-Ang Wu(4), Chuan-Chun Wu(4), Jia-Wei Wong(3), Shu-Min Liu(3), Jiann-Horng Lin(3), Chun-Hao Chen(3), Yeong-Chyi Lee(2), Duen-Chuan Yang(2), Feng‐Huei Lin(2), Subramaniam Sadhasivam(2), Chuen-Liang Chen(2), You-En Wei(2), Wen-Yung Lee(1)